May 17 (Reuters) - Inventiva SA IVAA.PA :
* INVENTIVA REPORTS 2023 FIRST QUARTER FINANCIAL INFORMATION
AND
PROVIDES A CORPORATE UPDATE
* CASH AND CASH EQUIVALENTS AT €56.3 MILLION, SHORT-TERM
DEPOSITS
AT €0.7 MILLION, AND LONG TERM DEPOSIT AT €9.3 MILLION AS OF
MARCH 31, 2023, COMPARED TO €86.7 MILLION, €1.0 MILLION AND €0.7
MILLION AS OF DECEMBER 31, 2022, RESPECTIVELY
* FIRST VISIT OF THE LAST PATIENT FOR NATIV3 IS TARGETED FOR
THE
SECOND HALF OF 2023
* TOPLINE RESULTS OF THE STUDY WITH LANIFIBRANOR IN PATIENTS
WITH
NAFLD AND T2D EXPECTED IN THE MIDDLE OF Q2 2023
Source text for Eikon: ID:nGNXc5VxTt
Further company coverage: IVAA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))